| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | -$2.9M | -670.2% |
| R&D Expense | $10.2M | +18.9% |
| SG&A Expense | $4.9M | +20.7% |
| Operating Income | -$17.9M | -48.0% |
| Interest Expense | $27K | +0.0% |
| Pre-tax Income | -$16.4M | -52.0% |
| Income Tax | $755 | +10.9% |
| Net Income | -$16.4M | -52.0% |
| EPS (Basic) | -$3.10 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.8M | +51.6% |
| Current Assets | $22.9M | -33.0% |
| Total Assets | $23.0M | -38.7% |
| Current Liabilities | $2.6M | +56.8% |
| Total Liabilities | $2.6M | +37.9% |
| Stockholders' Equity | $20.4M | -42.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.9M | +0.9% |
| Capital Expenditures | $13K | -90.2% |
| Investing Cash Flow | $13.1M | -8.5% |
| Financing Cash Flow | $405K | +119.0% |
| Free Cash Flow | -$11.9M | +1.8% |
| -2483.3% |
| EPS (Diluted) | -$3.14 | -2315.4% |